A2AR正性别构调节剂改善小鼠银屑病样皮炎
本研究探索A2AR正性别构调节剂AEA061对咪喹莫特诱导和IL-23诱导的小鼠银屑病样皮炎的作用。口服或局部给予AEA061可减轻耳肿胀、皮肤厚度、红斑、鳞屑及炎症细胞因子表达,且该效应依赖A2AR。AEA061还抑制pDC产生IFN-α、cDC产生IL-23和IL-36α以及γδT细胞和CD4+ T细胞产生IL-17。
要点
- AEA061口服或局部给药均改善小鼠银屑病样皮炎。
- AEA061的疗效依赖A2AR,A2AR缺失小鼠无效。
- AEA061抑制pDC、cDC及T细胞相关炎症因子。
核心结论
- 通过正性别构调节增强A2AR对内源性腺苷的反应性,足以增强内在稳态机制并减缓疾病进展。
研究设计与样本
- 使用咪喹莫特诱导的银屑病样皮炎小鼠模型,比较A2Ar+/+与A2Ar-/-小鼠。
- 使用IL-23诱导的银屑病样皮炎小鼠模型。
- AEA061通过口服和局部两种途径给药。
主要发现
- 口服AEA061减轻A2Ar+/+小鼠而非A2Ar-/-小鼠的耳肿胀、皮肤厚度、红斑、鳞屑形成和炎症细胞因子表达。
- 局部给予AEA061观察到类似的临床和mRNA改善。
- AEA061降低IL-23诱导的小鼠模型中的临床评分和细胞因子表达。
- AEA061减弱咪喹莫特诱导的pDC中IFN-α表达以及cDC中IL-23和IL-36α表达。
- AEA061抑制体内γδT细胞中TCR介导的IL-17表达以及体外富集γδT细胞的CD4+ T细胞产生IL-17。
临床怎么用
- A2AR正性别构调节可能成为银屑病等炎症性皮肤病的一种潜在治疗策略。
局限性
- 证据来自小鼠模型,尚未在人体中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Psoriasis is an immune cell‒mediated inflammatory disease of the skin with a mixed T helper type 1/T helper type17 cytokine environment combined with an innate immune response engaging toll-like receptors. Inflammatory diseases are characterized by dysregulated immune cell responses and elevated levels of adenosine at disease sites. Adenosine, acting through the A2AR, regulates inflammation, immune response, T-cell homeostasis, and tissue repair. We have identified a unique means to enhance A2AR function using a positive allosteric modulator. We show that oral administration of the A2AR-positive allosteric modulator AEA061 reduced ear swelling, skin thickness, erythema, scale formation, and inflammatory cytokine expression in A2Ar+/+ but not in A2Ar-/- mice with imiquimod-induced psoriasis-like dermatitis. Similar clinical and mRNA improvements were observed with topical administration. AEA061 also reduced clinical scores and cytokine expression in a mouse model of IL-23‒induced psoriasis-like dermatitis. In addition, AEA061 attenuated imiquimod-induced expression of IFN-α in plasmacytoid dendritic cells in vivo and IL-23 and IL-36α in conventional dendritic cells. TCR-mediated IL-17 expression in γδT cells in vivo and IL-17 production by CD4+ T cells enriched for γδT cells in vitro were also inhibited. Thus, the enhancement of A2AR responsiveness to the endogenous agonist adenosine through positive allosteric modulation is sufficient to enhance intrinsic homeostatic mechanisms attenuating disease progression.
引用
- Welihinda A, Ravikumar P, Kaur M, et al. Positive Allosteric Modulation of A2AR Alters Immune Cell Responses and Ameliorates Psoriasis-Like Dermatitis in Mice. J Invest Dermatol. 2021. PMID: 34536482. doi:10.1016/j.jid.2021.07.174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。